Rb. Kimble et al., SIMULTANEOUS BLOCK OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR IS REQUIRED TO COMPLETELY PREVENT BONE LOSS IN THE EARLY POSTOVARIECTOMY PERIOD, Endocrinology, 136(7), 1995, pp. 3054-3061
Considerable evidence supports the hypothesis that estrogen prevents b
one loss by blocking the production of cytokines in bone or bone marro
w. However, controversy remains on the role of candidate factors, such
as interleukin-1 (IL-1), IL-6, and tumor necrosis factor (TNF). As IL
-1 and TNF have many additive and/or synergistic effects in hone, we t
ested the hypothesis that the simultaneous block of IL-1 and TNF is re
quired to prevent the initial phase of rapid bone loss that follows ov
ariectomy (ovx). To this aim, rats were ovariectomized and treated for
2 weeks with either IL-1 receptor antagonist (IL-1ra), an inhibitor o
f IL-1, or TNF-binding protein (TNFbp), an inhibitor TNF. Ovx increase
d bone marrow cell secretion of IL-1 and TNF and decreased the bone de
nsity of the distal femur, as measured by dual energy x-ray absorptiom
etry. Ovx-induced bone loss was decreased by both IL-1ra and TNFbp and
completely prevented by simultaneous treatment with IL-1-1ra and TMFb
p. Combined treatment with IL-1ra and TNFbp decreased urinary pyridino
line cross-links, a marker of bone resorption that reflects osteoclast
number and osteoclast activity, whereas treatment with either inhibit
or alone was less effective. Both IL-1ra and TNFbp decreased the numbe
r of osteoclasts on the endocortical surfaces and stimulated bone form
ation, but the two inhibitors had no additive effects on these indexes
, suggesting that inhibition of osteoclastogenesis and stimulation of
bone formation do not account for the additive bone-sparing effects of
IL-1ra and TNFbp. These inhibitors had no effect in sham-operated rat
s, indicating that they specifically blocked estrogen-dependent events
. In conclusion, these data indicate that in the early post-ovx period
, IL-1 and TNF play a critical causal role in inducing bone loss and d
o so by stimulating bone resorption and inhibiting bone formation.